verteporfin: profile and news






Triple Regimen Safe and Effective for Choroidal Neovascularization ...  May 2, 2006
Patients received 10 mg of intravitreal triamcinolone initially, followed by standard verteporfin PDT, and finally, intravitreal injections of Macugen 0.3 mg ... - DG News

QLT announces Visudyne(R) sales for first quarter of 2006  Apr 23, 2006
...(NASDAQ: QLTI; TSX: QLT) today reported that Novartis AG announced global sales of QLT's Visudyne(R) (verteporfin) product of approximately US$106.8 million ... - MSN Money

QLT Announces Visudyne Sales for First Quarter of 2006  Apr 24, 2006
...today reported that Novartis AG announced global sales of QLT's Visudyne(R) (verteporfin) product of approximately US$106.8 million for the quarter ended March ... - PharmaLive.com (press release),

QLT announces Visudyne(R) sales for first quarter of 2006  Apr 23, 2006
...(NASDAQ: QLTI - News; TSX: QLT - News) today reported that Novartis AG announced global sales of QLT's Visudyne® (verteporfin) product of approximately US ... - Yahoo! News (press release)


Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org